breast

Cancer market commentary: 3 highlights from ESMO (Part 1)

https://pharmaphorum.com/esmo-2016/cancer-market-commentary-3-highlights-esmo-conference-part-1/

Medivation in merger talks with Sanofi and others

https://pharmaphorum.com/news/medivation-takeover-talks-sanofi-others/

Possible new breast cancer use for AZ’s Faslodex

https://pharmaphorum.com/news/possible-new-breast-cancer-use-for-azs-faslodex-after-phase-iii-success/

Close in 10 seconds

Pharmaphorum.com

Search